An Act relative to pharmaceutical access, costs and transparency
Summary
Senate, February 10, 2022 -- Text of the Senate Bill relative to pharmaceutical access, costs and transparency (being the text of Senate, No. 2651, printed as amended).
Bill status
passed
3 of 5 stages cleared
Introduction
Feb 2022
Committee Review
Feb 2022
Senate Passage
Feb 2022
House Passage
Governor
Introduced Feb 10, 2022
Last action Feb 15, 2022
Floor votes · Senate Feb 10, 2022
How they voted
39–1
Passed
Total votes 40
Feb 10, 2022
D
Democratic37
100% Yea
R
Republican3
66% Yea
Vote distribution
All Yea
All Nay
Mixed
No data
Full legislative history
Actions timeline
Total actions
3
Key actions
1
Committee
1
Amendments
1
Feb 15, 2022
Committee
Read; and referred to the committee on House Ways and Means
lower
Feb 10, 2022
Upper · Passed
Passed to be engrossed -see Roll Call #129 (Yeas 39 to Nays 1)
upper
Feb 10, 2022
Introduced
Text of S2651, printed as amended
upper
0 primary · 12 co-sponsors
Sponsors
No sponsor information available.
Ask Maddy
·
AI policy assistant
Ask Maddy about S 2695
Scope: MA
Hi! I can help you understand S 2695. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline